Read further: Evaluating Secondary T-Cell Malignancies as Adverse Reactions to CAR T-Cell Therapy
You may also like
Real-World Effectiveness of Nirsevimab in Preventing...
Comparison of Hypotension-Avoidance and Hypertension...
Digital Cognitive Assessments in Primary Care:...
Addressing Cardiometabolic Risks in South Asians: A...
Tracking Early Cardiac Development: Insights from Live...
Cardiac Digital Twins: Advancing Personalized Insights...
About the author
